In puromycin‐reduced U937 (human tumor monocytes) model, melatonin (1 mM) promotes the mitochondrial localization of Bcl‐2 and interferes with the activation of Bax, thereby inhibiting apoptosis and exerting its anti‐apoptotic effects (Radogna et al. This evidence concerns the gene BCL2 and neoplasm.